By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PharmAthene, Inc. 

One Park Place
Suite 450
Annapolis  Maryland  21401  U.S.A.
Phone: 410-269-2600 Fax: 410-269-2601


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Immunovaccine Inc. And PharmAthene, Inc. (PIP) Sign Exclusive Worldwide License Agreement To Develop And Commercialize An Anthrax Vaccine Formulated In DepoVax 7/8/2015 10:52:03 AM
PharmAthene, Inc. (PIP) Reports First Quarter 2015 Financial and Operational Results 5/8/2015 6:52:46 AM
PharmAthene, Inc. (PIP) Receives $5.8 Million Payment From BARDA 4/13/2015 6:57:44 AM
PharmAthene, Inc. (PIP) Reports Year-End 2014 Financial And Operational Results; Announces Plan To Realign Operational Resources 3/10/2015 7:48:31 AM
PharmAthene, Inc. (PIP) rPA Antigen Formulated With DepoVax™ Demonstrates Promise As Single Unit Dose Anthrax Vaccine 2/2/2015 10:28:06 AM
PharmAthene, Inc. (PIP) Awarded $195 Million Plus Post-Judgment Interest By Delaware Court Of Chancery 1/16/2015 9:54:46 AM
Court Orders SIGA Technologies, Inc. (SIGA) to Pay PharmAthene, Inc. (PIP) $113 Million 1/8/2015 6:03:46 AM
PharmAthene, Inc. (PIP) Fulfills Valortim IDIQ Contract 11/20/2014 12:39:53 PM
PharmAthene, Inc. (PIP) Provides Third Quarter 2014 Operational And Financial Update 11/7/2014 7:53:29 AM
PharmAthene, Inc. (PIP) Announces U.S. Bankruptcy Court Partially Lifts Litigation Stay To Permit Delaware Court To Proceed Towards Final Judgment 10/8/2014 10:47:19 AM
12345678910...
//-->